Mach7 Technologies Ltd. ( (TDMMF) ) has released its Q4 earnings. Here is a breakdown of the information Mach7 Technologies Ltd. presented to its investors.
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Mach7 Technologies Ltd., an Australian company, specializes in developing medical imaging software solutions for healthcare organizations worldwide, offering products like the eUnity Enterprise Diagnostic Viewer and Vendor Neutral Archive. In its latest earnings report for the fiscal year ending June 2025, Mach7 Technologies reported a 16% increase in revenue to AUD 33.8 million, while reducing its net loss by 22% to AUD 6.2 million compared to the previous year. The company’s sales orders totaled AUD 29.1 million, with a significant portion coming from annual recurring revenue, reflecting a shift towards subscription-based sales. Despite a challenging market, Mach7 maintained a strong gross margin of 94% and achieved positive operating cash flow, ending the year with AUD 23.1 million in cash reserves. Looking ahead, Mach7 Technologies aims to capitalize on its innovative product offerings and customer-centric strategies to drive growth, particularly focusing on expanding its market share in North America, Asia Pacific, and the Middle East.